Delivery Order SPE2DE21D7010-SPE2D625F56EG

Award Date 1/27/25
Potential Completion Date 2/21/25
Potential Value $17K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,971.70, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Fixed Price with Economic Price Adjustment Delivery Order for the reline of open implants, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
This federal contract award is for $40,819.90 and was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of June 30, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is not associated...
This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment mechanism, with an ultimate completion date of May 14, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under a Fixed Price with Economic Price Adjustment pricing type, with a period of performance through February 10, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price and economic price adjustment pricing type, and has an ultimate completion date of May 23, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized spinal medical...
This federal contract award, valued at $29,781.18, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of January 31, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
This federal contract award, valued at $19,285.20, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and an ultimate completion date of April 2, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit organization....
This federal contract award, valued at $46,038.63, was issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment pricing type, with a period of performance ending on March 17, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is part of a larger $8 million Blanket...
This federal contract award is a delivery order (SPE2DE21D7010|SPE2D625F0N6K) valued at $31,469.80 issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. Nuvasive is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division. The contract provides a range of spinal medical devices and surgical instruments to support orthopedic, neurological, and reconstructive surgeries at...
This federal contract award, valued at $18,454.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order under a larger Blanket Purchase Agreement (BPA) valued at $8 million that Nuvasive holds with the Defense Health Agency (DHA). This BPA serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, allowing DHA and Department of...
  • SPE2DE21D7010
    Indefinite Delivery Contract
  • SPE2DE21D7010-SPE2D625F56EG
    Delivery Order

This federal contract award, valued at $17,360.46, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of February 21, 2025.

Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and operates as a for-profit organization. The company has established itself as a key supplier of specialized medical technologies to the U.S. Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA), with a focus on delivering cutting-edge spinal medical devices and surgical solutions.

This contract is not associated with any set-aside designation, indicating Nuvasive's strong market position in providing specialized medical technologies. The contract vehicle includes an $8 million single-award Blanket Purchase Agreement (BPA) with the Defense Health Agency, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract through March 2027. This BPA allows DoD and VA medical facilities to efficiently access Nuvasive's portfolio of spinal medical devices and instruments, supporting the DHA's mission of providing advanced medical solutions for military health system patients.

Generated 4/28/25, 9:42 AM